We are live on ! Find out more
CC icon

Chemours
CC

506 hedge funds and large institutions have $3.79B invested in Chemours in 2018 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 137 increasing their positions, 173 reducing their positions, and 128 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 6 → 9 (+3)

41% more call options, than puts

Call options by funds: $26.4M | Put options by funds: $18.8M

1.75% more ownership

Funds ownership: 76.97% → 78.72% (+1.8%)

8% less funds holding

Funds holding: 551 → 506 (-45)

21% less repeat investments, than reductions

Existing positions increased: 137 | Existing positions reduced: 173

30% less capital invested

Capital invested by funds: $5.42B → $3.79B (-$1.63B)

32% less first-time investments, than exits

New positions opened: 87 | Existing positions closed: 128

Holders
506
Holders Change
-45
Holders Change %
-8.17%
% of All Funds
11.27%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.2%
New
87
Increased
137
Reduced
173
Closed
128
Calls
$26.4M
Puts
$18.8M
Net Calls
+$7.62M
Net Calls Change
+$45.4M

Top Buyers

Rank Fund Capital Flow
1
TCIM
TIAA CREF Investment Management
New York
+$62.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$56M
3
LSV Asset Management
LSV Asset Management
Illinois
+$35.6M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$27.2M
5
LM
Luminus Management
Texas
+$24M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$63.8M
2
Marshall Wace
Marshall Wace
United Kingdom
-$55.1M
3
Prudential Financial
Prudential Financial
New Jersey
-$48.3M
4
AAM
Ardevora Asset Management
United Kingdom
-$35.5M
5
GCM
Gates Capital Management
New York
-$28.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
101
MetLife Investment Management
New Jersey
$2.94M -$125K -3,950 -4%
SCM
102
SIR Capital Management
New York
$2.87M -$10.2M -321,202 -76%
T. Rowe Price Associates
103
T. Rowe Price Associates
Maryland
$2.85M -$404K -12,763 -11%
BI
104
Bredin Investment
Delaware
$2.83M – – –
Barclays
105
Barclays
United Kingdom
$2.82M -$5.7M -180,208 -64%
MSL
106
Mackay Shields LLC
New York
$2.7M -$5.56M -175,779 -65%
Jacobs Levy Equity Management
107
Jacobs Levy Equity Management
New Jersey
$2.7M -$67.7K -2,140 -2%
Lazard Asset Management
108
Lazard Asset Management
New York
$2.7M +$266K +8,404 +10%
OPERF
109
Oregon Public Employees Retirement Fund
Oregon
$2.67M +$701K +22,168 +31%
Robeco Institutional Asset Management
110
Robeco Institutional Asset Management
Netherlands
$2.59M +$2.95M +93,172 New
FAF
111
Fjarde Ap-fonden
Sweden
$2.55M +$845K +26,700 +42%
GC
112
Guggenheim Capital
Illinois
$2.55M +$422K +13,345 +17%
MSA
113
Mason Street Advisors
Wisconsin
$2.53M -$38.4K -1,214 -1%
ECM
114
Element Capital Management
New York
$2.5M +$1.52M +48,090 +118%
UBS Group
115
UBS Group
Switzerland
$2.46M -$1.27M -40,079 -32%
CANY
116
Caxton Associates (New York)
New York
$2.45M +$2.74M +86,759 New
CCI
117
Credit Capital Investments
New Jersey
$2.43M -$380K -12,000 -12%
SM
118
Soapstone Management
Maryland
$2.4M +$2.69M +85,000 New
First Trust Advisors
119
First Trust Advisors
Illinois
$2.37M -$304K -9,607 -10%
GIA
120
Gateway Investment Advisers
Ohio
$2.35M +$558K +17,634 +27%
Holocene Advisors
121
Holocene Advisors
New York
$2.35M -$5.23M -165,443 -67%
RIM
122
Redpoint Investment Management
Australia
$2.31M -$281K -8,885 -10%
UH
123
Unigestion Holding
Switzerland
$2.11M +$2.36M +74,658 New
SF
124
Susquehanna Foundation
Pennsylvania
$2.09M – – –
BCM
125
Bridgeway Capital Management
Texas
$2.05M +$63.3K +2,000 +3%
3 4
5
6 7

CC Hedge Fund Activity: Q4 2018 in Review

506 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2018, worth a combined $3.79B — down 30% from $5.42B a quarter earlier.

Sellers outnumbered buyers: 128 funds closed out of CC and 87 opened new positions — a net loss of 41 holders — while 173 trimmed existing stakes and 137 added.

The largest buyer was TIAA CREF Investment Management, adding an estimated $62.6M. The largest seller was Fidelity Investments, cutting an estimated $63.8M.

  • 506 institutional investors held Chemours (CC) as of Q4 2018, down from 551 in Q3 2018.
  • Funds reported $3.79B of Chemours stock for Q4 2018, down 30% quarter-over-quarter.
  • 87 funds opened new Chemours positions in Q4 2018 and 128 closed out, a net change of -41 holders.
  • The largest Chemours buyer in Q4 2018 was TIAA CREF Investment Management, an estimated $62.6M added.
  • The largest Chemours seller in Q4 2018 was Fidelity Investments, an estimated $63.8M sold.

Based on aggregated 13F filings for Q4 2018.